Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mix vaccine in metastatic kidney cancer
NCT03357289Phase 2Completed
- Sponsor
- Fuda Cancer Hospital
- Start
- Nov 2017
- Primary completion
- Nov 2018
- Modality
- Cell Therapies, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of mix vaccine in kidney cancer, sponsored by Fuda Cancer Hospital. Started Nov 2017; status: completed.
02
Drugs
mix vaccine
03
Conditions
kidney cancer
Beyond the preview
Go deeper on NCT03357289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03357289.